Scientific Program Partner
Meeting agenda created in conjunction with The Antibody Society.
Marriott Marquis San Diego,
Live In-Person Event: December 14 - 17, 2025
The #1 Antibody and Protein Conference: Your Path to Commercial Success
Unlock the opportunity to be part of discussions on breakthrough topics like bispecifics, ADCs, and antibody-based therapies for cancer and neurodegenerative diseases and much more...
🚨 Become a Speaker 🚨
Your groundbreaking research deserves the spotlight at 2025's biggest antibody engineering event.
In 2024 we brought you:
+
World-Class Speaker Presentations
+
Antibody Scientists & Executives
+
Leading Industry Exhibitors
+
Scientific Posters Highlighting Breakthrough Research
Eary Confirmed Keynotes for 2025!
Get the Latest Updates on 2025 Antibody Events
Were You There? Watch the Highlights!
Relive the key moments, inspiring talks, and buzzing networking sessions from Antibody Engineering & Therapeutics. If you missed it, now’s your chance to see why this is the leading event shaping the future of antibody science.
Be part of the action in 2025, register your interest today >
Explore 10 Pioneering Antibody Innovations → Scroll to Find Your Session
Explore therapeutic innovation with antibody-based degraders, targeting and degrading problematic proteins, revolutionizing cancer treatment.
Discover the intersection of research and clinical application, highlighting how reverse translation medicine is transforming therapeutics and improving the accuracy of drug efficacy and safety predictions.
Stay at the forefront of bispecific and multi-specific antibodies, and learn how these advanced therapies targeting multiple antigens are improving treatment for complex diseases.
Uncover advancements in antibody therapies for metabolic and neurodegenerative diseases, with innovative approaches in design and delivery for diabetes, Alzheimer’s, and Parkinson’s.
Discover evolving antibody-based therapies for autoimmune diseases, focusing on precise immune targeting and minimizing off-target effects.
Engage with innovations in cell engager technologies that harness the immune system for selective cancer cell targeting and enhanced immunotherapy precision.
Explore cutting-edge in-vivo techniques for therapeutic antibodies, such as transgenic models and high-throughput screening, accelerating high-affinity, specific antibody development.
Stay ahead with emerging in vitro antibody discovery techniques, like phage display and cell-free systems, that speed up antibody identification and optimization.
Discover innovations in antibody-drug conjugates (ADCs) that enhance targeting precision and combine cytotoxic drugs for improved efficacy and reduced side effects.
Expand your knowledge of unconventional antibody formats, such as single-domain antibodies and nanobodies, and their benefits in size, stability, and tissue penetration.
About the Antibody Society
The Antibody Society is an international, non-profit trade association serving individuals and organizations involved in antibody-related research and development. We research and analyze data on targeted therapeutics developed by the biopharmaceutical industry, and distribute our results and commentary via the Society’s website, presentations and publications. The Society hosts educational webinars and Symposia, and serves as the home for the Adaptive Immune Receptor Repertoire (AIRR) Community, which focuses on the generation, use, sharing and standardization of next-generation sequencing of antibodies and T cell receptors. In addition, we engage with international agencies on matters of importance to the antibody community.
Our members serve as the Scientific Advisors for the Antibody Engineering & Therapeutics conferences. The scientific programs for the meetings are designed by our Meetings Committee.
